Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
Bb
Description:
An abbreviation that can refer to the complement protein fragment Bb, generated during activation of the alternative complement pathway.
Primary topic:
Complement system in diseases (48%)
Related topics:
Complement system in diseases (48%),
Systemic Lupus Erythematosus Research (11%)
OpenAlex ID:
keywords/bb
Molecular Biology and Chemistry of the Alternative Pathway of Complement
1980
·
Hans J. Müller-Eberhard
, Robert D. Schreiber
·
Advances in immunology
·
428
Plasma Complement Components and Activation Fragments: Associations with Age-Related Macular Degeneration Genotypes and Phenotypes
2009
·
Robyn Reynolds
, M. Elizabeth Hartnett
, et al.
·
Investigative Ophthalmology & Visual Science
·
325
Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody–associated vasculitis
2012
·
Shen-Ju Gou
, Jun Yuan
, et al.
·
Kidney International
·
294
PDF
A Review of Complement Activation in SLE
2021
·
Arthur Weinstein
, Roberta V. Alexander
, et al.
·
Current Rheumatology Reports
·
241
PDF
The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.
1987
·
T Fujita
, T Inoue
, et al.
·
The Journal of Experimental Medicine
·
220
PDF
Alternative Complement Pathway Activation Products in Urine and Kidneys of Patients with ANCA-Associated GN
2013
·
Shen-Ju Gou
, Jun Yuan
, et al.
·
Clinical Journal of the American Society of Nephrology
·
191
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies
2018
·
Mimi Y Kim
, Marta M Guerra
, et al.
·
Annals of the Rheumatic Diseases
·
187
The complement system in ischemic heart disease.
1990
·
M Yasuda
, K Takeuchi
, et al.
·
Circulation
·
134
PDF
Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity
1996
·
Susan Manzi
, Joan E. Rairie
, et al.
·
Arthritis & Rheumatism
·
123
Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement
1992
·
Jill P. Buyon
, John Tamerius
, et al.
·
Arthritis & Rheumatism
·
118
C3 Requirements for Formation of Alternative Pathway C5 Convertase
1976
·
Mohamed R Daha
, Douglas T Fearon
, et al.
·
The Journal of Immunology
·
113
Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin
2013
·
Martín Alcorlo
, Agustín Tortajada
, et al.
·
Proceedings of the National Academy of Sciences
·
110
Activation of the Alternative Complement Pathway Accompanies Disease Flares in Systemic Lupus Erythematosus During Pregnancy
1992
·
Jill P. Buyon
, John Tamerius
, et al.
·
Arthritis & Rheumatism
·
100
Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis
2015
·
Lucio Manenti
, Augusto Vaglio
, et al.
·
Clinical Journal of the American Society of Nephrology
·
92
Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
1986
·
M K Pangburn
·
The Journal of Immunology
·
88
MHC Class III products: an electron microscopic study of the C3 convertases of human complement.
1984
·
C A Smith
, C W Vogel
, et al.
·
The Journal of Experimental Medicine
·
85
PDF
Complement activation products in the circulation and urine of primary membranous nephropathy
2019
·
Mu-fan Zhang
, Jing Huang
, et al.
·
BMC Nephrology
·
82
PDF
Traumatic brain injury increases plasma astrocyte‐derived exosome levels of neurotoxic complement proteins
2020
·
Edward J. Goetzl
, Kristine Yaffe
, et al.
·
The FASEB Journal
·
79
PDF
Complement activation associated with polysorbate 80 in beagle dogs
2012
·
Shidong Qiu
, Zhaohua Liu
, et al.
·
International Immunopharmacology
·
72
The Excessive Complement Activation in Fulminant Meningococcal Septicemia Is Predominantly Caused by Alternative Pathway Activation
1996
·
P. Brandtzaeg
, K. Hagasen
, et al.
·
The Journal of Infectious Diseases
·
69
Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking
2016
·
Guankui Wang
, Fangfang Chen
, et al.
·
Frontiers in Immunology
·
61
PDF
Simultaneous assessment of complement components C3, C4, and B and their cleavage products in human gingival fluid: II. Longitudinal changes during periodontal therapy
1985
·
Christine E. Niekrash
, Mark R. Patters
·
Journal of Periodontal Research
·
61
Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor.
1981
·
M R Daha
, L A Van Es
·
PubMed
·
61
Complement activation profile of patients with primary focal segmental glomerulosclerosis
2020
·
Jing Huang
, Zhao Cui
, et al.
·
PLoS ONE
·
58
PDF
C3 convertase of the alternative complement pathway. Demonstration of an active, stable C3b, Bb (Ni) complex.
1983
·
Z Fishelson
, M K Pangburn
, et al.
·
Journal of Biological Chemistry
·
58
Show more works
View as search
Works count:
138
Citation count:
4,654
Year
Topic
Type